IKKβ/NF-κB activation causes severe muscle wasting in mice

Cell

Volumn 119, Issue 2, 2004, Pages 285-298

  Cai, Dongsheng ^a,f   Frantz, J Daniel ^a,f   Tawa Jr , Nicholas E ^b,f   Melendez, Peter A ^a,f   Oh, Byung Chul ^a,f   Lidov, Hart G W ^c,f   Hasselgren, Per Olof ^b,f   Frontera, Walter R ^d,f   Lee, Jongsoon ^a,f   Glass, David J ^e   Shoelson, Steven E ^a,f  

^a JOSLIN DIABETES CENTER   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d American Journal of Physical Medicine and Rehabilitation   (United States)

^e REGENERON PHARMACEUTICALS INC   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; UBIQUITIN; CHUK PROTEIN, HUMAN; CHUK PROTEIN, MOUSE; CYTOKINE; ENZYME INHIBITOR; I KAPPA B KINASE; IKBKB PROTEIN, HUMAN; IKBKB PROTEIN, MOUSE; IKBKE PROTEIN, HUMAN; IKBKE PROTEIN, MOUSE; PROTEIN SERINE THREONINE KINASE; SALICYLIC ACID DERIVATIVE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CACHEXIA; CARCINOGENESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DENERVATION; GENE EXPRESSION; MOUSE; MUSCLE ATROPHY; NONHUMAN; PATHOGENESIS; PHARMACOGENETICS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION; SURVIVAL RATE; TRANSGENE; ANIMAL; BODY WEIGHT; CANCER TRANSPLANTATION; CELL LINE; ENZYME ACTIVATION; FEMALE; GENETICS; HINDLIMB; HUMAN; INNERVATION; MALE; METABOLISM; ORGAN SIZE; PATHOLOGY; SKELETAL MUSCLE; TRANSGENIC MOUSE;

ANIMALIA;

ANIMALS; BODY WEIGHT; CACHEXIA; CELL LINE; CYTOKINES; ENZYME ACTIVATION; ENZYME INHIBITORS; FEMALE; HINDLIMB; HUMANS; I-KAPPA B KINASE; MALE; MICE; MICE, TRANSGENIC; MUSCLE, SKELETAL; MUSCULAR ATROPHY; NEOPLASM TRANSPLANTATION; NF-KAPPA B; ORGAN SIZE; PHENOTYPE; PROTEIN-SERINE-THREONINE KINASES; SALICYLATES; SIGNAL TRANSDUCTION; SURVIVAL RATE; UBIQUITIN;

EID: 5444262078     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2004.09.027     Document Type: Article

References (45)

1. Argiles J.M., Lopez-Soriano F.J. The role of cytokines in cancer cachexia. Med. Res. Rev. 19:1999;223-248
2. Baeuerle P.A., Baltimore D. Nf-κb. ten years after Cell. 87:1996;13-20
3. Bodine S.C., Latres E., Baumhueter S., Lai V.K., Nunez L., Clarke B.A., Poueymirou W.T., Panaro F.J., Na E., Dharmarajan K., et al. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science. 294:2001;1704-1708
4. Carpenter S., Karpati G. Pathology of Skeletal Muscle. 2001;Oxford University Press, Oxford
5. Coletti D., Yang E., Marazzi G., Sassoon D. TNFα inhibits skeletal myogenesis through a PW1-dependent pathway by recruitment of caspase pathways. EMBO J. 21:2002;631-642
6. Delhase M., Hayakawa M., Chen Y., Karin M. Positive and negative regulation of IκB kinase activity through IKKβ subunit phosphorylation. Science. 284:1999;309-313
7. Donoviel D.B., Shield M.A., Buskin J.N., Haugen H.S., Clegg C.H., Hauschka S.D. Analysis of muscle creatine kinase gene regulatory elements in skeletal and cardiac muscles of transgenic mice. Mol. Cell. Biol. 16:1996;1649-1658
8. Fang C.H., Li B.G., Tiao G., Wang J.J., Fischer J.E., Hasselgren P.O. The molecular regulation of protein breakdown following burn injury is different in fast- and slow-twitch skeletal muscle. Int. J. Mol. Med. 1:1998;163-169
9. Fiorucci S., Antonelli E., Distrutti E., Del Soldato P., Flower R.J., Clark M.J., Morelli A., Perretti M., Ignarro L.J. NCX-1015, a nitric-oxide derivative of prednisolone, enhances regulatory T cells in the lamina propria and protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis in mice. Proc. Natl. Acad. Sci. USA. 99:2002;15770-15775
10. Fong Y., Moldawer L.L., Marano M., Wei H., Barber A., Manogue K., Tracey K.J., Kuo G., Fischman D.A., Cerami A. Cachectin/TNF or IL-1α induces cachexia with redistribution of body proteins. Am. J. Physiol. 256:1989;R659-R665
11. Glass D.J. Signalling pathways that mediate skeletal muscle hypertrophy and atrophy. Nat. Cell Biol. 5:2003;87-90
12. Gomes M.D., Lecker S.H., Jagoe R.T., Navon A., Goldberg A.L. Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc. Natl. Acad. Sci. USA. 98:2001;14440-14445
13. Guttridge D.C., Mayo M.W., Madrid L.V., Wang C.Y., Baldwin A.S. Jr. NF-κB-induced loss of MyoD messenger RNA. possible role in muscle decay and cachexia Science. 289:2000;2363-2366
14. Hunter R.B., Stevenson E., Koncarevic A., Mitchell-Felton H., Essig D.A., Kandarian S.C. Activation of an alternative NF-κB pathway in skeletal muscle during disuse atrophy. FASEB J. 16:2002;529-538
15. Jagoe R.T., Goldberg A.L. What do we really know about the ubiquitin-proteasome pathway in muscle atrophy? Curr. Opin. Clin. Nutr. Metab. Care. 4:2001;183-190
16. Kopp E., Ghosh S. Inhibition of NF-κB by sodium salicylate and aspirin. Science. 265:1994;956-959
17. Kumar A., Boriek A.M. Mechanical stress activates the NF-κB pathway in skeletal muscle fibers. a possible role in Duchenne muscular dystrophy FASEB J. 17:2003;386-396
18. Ladner K.J., Caligiuri M.A., Guttridge D.C. Tumor necrosis factor-regulated biphasic activation of NF-κB is required for cytokine-induced loss of skeletal muscle gene products. J. Biol. Chem. 278:2003;2294-2303
19. Langen R.C., Schols A.M., Kelders M.C., Wouters E.F., Janssen-Heininger Y.M. Inflammatory cytokines inhibit myogenic differentiation through activation of NF-κB. FASEB J. 15:2001;1169-1180
20. Larsson L., Moss R.L. Maximum velocity of shortening in relation to myosin isoform composition in single fibres from human skeletal muscles. J. Physiol. 472:1993;595-614
21. Lecker S.H., Solomon V., Mitch W.E., Goldberg A.L. Muscle protein breakdown and the critical role of the ubiquitin-proteasome pathway in normal and disease states. J. Nutr. 129:1999;227S-237S
22. Li Y.P. TNF-α is a mitogen in skeletal muscle. Am. J. Physiol. 285:2003;C370-C376
23. Li Y.P., Reid M.B. NF-κB mediates the protein loss induced by TNF-α in differentiated skeletal muscle myotubes. Am. J. Physiol. 279:2000;R1165-R1170
24. Li Y.P., Chen Y., Li A.S., Reid M.B. Hydrogen peroxide stimulates ubiquitin-conjugating activity and expression of genes for specific E2 and E3 proteins in skeletal muscle myotubes. Am. J. Physiol. 285:2003;C806-C812
25. Ling L., Cao Z., Goeddel D.V. NF-κB-inducing kinase activates IKK-α by phosphorylation of Ser-176. Proc. Natl. Acad. Sci. USA. 95:1998;3792-3797
26. Lopez-Soriano J., Argiles J.M., Lopez-Soriano F.J. Lipid metabolism in rats bearing the Yoshida AH-130 ascites hepatoma. Mol. Cell. Biochem. 165:1996;17-23
27. Mercurio F., Murray B.W., Shevchenko A., Bennett B.L., Young D.B., Li J.W., Pascual G., Motiwala A., Zhu H., Mann M., Manning A.M. IκB kinase (IKK)-associated protein 1, a common component of the heterogeneous IKK complex. Mol. Cell. Biol. 19:1999;1526-1538
28. Moldawer L.L., Svaninger G., Gelin J., Lundholm K.G. Interleukin 1 and tumor necrosis factor do not regulate protein balance in skeletal muscle. Am. J. Physiol. 253:1987;C766-C773
29. Mora M. Fibrous-adipose replacement in skeletal muscle biopsy. Eur. Heart J. Suppl. D. 10:1989;103-104
30. Mullen B.J., Harris R.B., Patton J.S., Martin R.J. Recombinant TNF-α chronically administered in rats. lack of cachectic effect Proc. Soc. Exp. Biol. Med. 193:1990;318-325
31. Penner C.G., Gang G., Wray C., Fischer J.E., Hasselgren P.O. The transcription factors NF-κB and AP-1 are differentially regulated in skeletal muscle during sepsis. Biochem. Biophys. Res. Commun. 281:2001;1331-1336
32. Rossi F.F., Cangiano C., Muscaritoli M., Conversano L., Torelli G.F., Cascino A. Tumor-induced changes in host metabolism. a possible marker of neoplastic disease Nutrition. 11:1995;595-600
33. Rothwarf, D.M., and Karin, M. (2000). The NF-κB activation pathway: a paradigm in information transfer from membrane to nucleus. Science's STKE www.stke.org/cgi/content/full/OC_sigtrans/1999/5/re1.
34. Sandri M., Sandri C., Gilbert A., Skurk C., Calabria E., Picard A., Walsh K., Schiaffino S., Lecker S.H., Goldberg A.L. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell. 117:2004;399-412
35. Stewart C.E., Newcomb P.V., Holly J.M. Multifaceted roles of TNF-α in myoblast destruction. a multitude of signal transduction pathways J. Cell. Physiol. 198:2004;237-247
36. Stitt T.N., Drujan D., Clarke B.A., Panaro F., Timofeyva Y., Kline W.O., Gonzalez M., Yancopoulos G.D., Glass D.J. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol. Cell. 14:2004;395-403
37. Sylla B.S., Hung S.C., Davidson D.M., Hatzivassiliou E., Malinin N.L., Wallach D., Gilmore T.D., Kieff E., Mosialos G. Epstein-Barr virus-transforming protein latent infection membrane protein 1 activates transcription factor NF-kappaB through a pathway that includes the NF-κB-inducing kinase and the IκB kinases IKKα and IKKβ Proc. Natl. Acad. Sci. USA. 95:1998;10106-10111
38. Tawa N.E. Jr., Odessey R., Goldberg A.L. Inhibitors of the proteasome reduce the accelerated proteolysis in atrophying rat skeletal muscles. J. Clin. Invest. 100:1997;197-203
39. Tiao G., Lieberman M., Fischer J.E., Hasselgren P.O. Intracellular regulation of protein degradation during sepsis is different in fast- and slow-twitch muscle. Am. J. Physiol. 272:1997;R849-R856
40. Tisdale M.J. Biology of cachexia. J. Natl. Cancer Inst. 89:1997;1763-1773
41. Van Antwerp D.J., Martin S.J., Kafri T., Green D.R., Verma I.M. Suppression of TNF-α-induced apoptosis by NF-κB. Science. 274:1996;787-789
42. Wray C.J., Mammen J.M., Hershko D.D., Hasselgren P.O. Sepsis upregulates the gene expression of multiple ubiquitin ligases in skeletal muscle. Int. J. Biochem. Cell Biol. 35:2003;698-705
43. Yaron A., Hatzubai A., Davis M., Lavon I., Amit S., Manning A.M., Andersen J.S., Mann M., Mercurio F., Ben Neriah Y. Identification of the receptor component of the IκBα-ubiquitin ligase. Nature. 396:1998;590-594
44. Yin M.J., Yamamoto Y., Gaynor R.B. The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β Nature. 396:1998;77-80
45. Yuan M., Konstantopoulos N., Lee J., Hansen L., Li Z.W., Karin M., Shoelson S.E. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkb. Science. 293:2001;1673-1677